1. Home
  2. KOP vs SVRA Comparison

KOP vs SVRA Comparison

Compare KOP & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOP
  • SVRA
  • Stock Information
  • Founded
  • KOP 1988
  • SVRA 2007
  • Country
  • KOP United States
  • SVRA United States
  • Employees
  • KOP N/A
  • SVRA N/A
  • Industry
  • KOP Forest Products
  • SVRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • KOP Basic Materials
  • SVRA Health Care
  • Exchange
  • KOP Nasdaq
  • SVRA Nasdaq
  • Market Cap
  • KOP 646.3M
  • SVRA 528.3M
  • IPO Year
  • KOP 2006
  • SVRA N/A
  • Fundamental
  • Price
  • KOP $33.69
  • SVRA $2.21
  • Analyst Decision
  • KOP Buy
  • SVRA Buy
  • Analyst Count
  • KOP 1
  • SVRA 5
  • Target Price
  • KOP $64.00
  • SVRA $5.60
  • AVG Volume (30 Days)
  • KOP 120.3K
  • SVRA 1.2M
  • Earning Date
  • KOP 08-07-2025
  • SVRA 08-11-2025
  • Dividend Yield
  • KOP 0.95%
  • SVRA N/A
  • EPS Growth
  • KOP N/A
  • SVRA N/A
  • EPS
  • KOP 1.22
  • SVRA N/A
  • Revenue
  • KOP $2,051,000,000.00
  • SVRA N/A
  • Revenue This Year
  • KOP N/A
  • SVRA N/A
  • Revenue Next Year
  • KOP $2.61
  • SVRA N/A
  • P/E Ratio
  • KOP $27.51
  • SVRA N/A
  • Revenue Growth
  • KOP N/A
  • SVRA N/A
  • 52 Week Low
  • KOP $22.99
  • SVRA $1.89
  • 52 Week High
  • KOP $41.64
  • SVRA $5.11
  • Technical
  • Relative Strength Index (RSI)
  • KOP 63.06
  • SVRA 41.30
  • Support Level
  • KOP $31.55
  • SVRA $1.98
  • Resistance Level
  • KOP $34.20
  • SVRA $2.29
  • Average True Range (ATR)
  • KOP 0.84
  • SVRA 0.14
  • MACD
  • KOP 0.06
  • SVRA 0.02
  • Stochastic Oscillator
  • KOP 84.16
  • SVRA 42.19

About KOP Koppers Holdings Inc.

Koppers Holdings Inc through its subsidiaries, manufactures and sells wood products, wood treatment chemicals, and carbon compounds used in markets such as railroad, aluminum and steel, agriculture, utilities, and residential lumber. The company is organized into three business segments: railroad and utility products and services, performance chemicals, and carbon materials and chemicals. Its product portfolio includes treated and untreated wood products like crossties used in railroads, wood preservation chemicals, and carbon compounds such as creosote used in the treatment of wood crossties, among others. The majority of its revenue comes from the company's railroad and utility products and services segment, and more than half of the company's revenue is earned in the United States.

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Share on Social Networks: